Global Health Clinics Ltd

PINK:LRSNF USA Drug Manufacturers - Specialty & Generic
Market Cap
$10.33K
Market Cap Rank
#44907 Global
#14175 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$376.40
About

Global Health Clinics Ltd. operates in the cannabis industry. It operates medical clinics, which guide patients through the process of becoming legal users of marijuana. The company was formerly known as Leo Resources Inc. and changed its name to Global Health Clinics Ltd. in August 2018. Global Health Clinics Ltd. was incorporated in 2013 and is headquartered in Vancouver, Canada.

Global Health Clinics Ltd (LRSNF) - Net Assets

Latest net assets as of October 2025: $-4.86 Million USD

Based on the latest financial reports, Global Health Clinics Ltd (LRSNF) has net assets worth $-4.86 Million USD as of October 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($66.47K) and total liabilities ($4.93 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-4.86 Million
% of Total Assets -7312.85%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change -24839.7%
Growth Volatility 21715.04

Global Health Clinics Ltd - Net Assets Trend (2014–2025)

This chart illustrates how Global Health Clinics Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Global Health Clinics Ltd (2014–2025)

The table below shows the annual net assets of Global Health Clinics Ltd from 2014 to 2025.

Year Net Assets Change
2025-07-31 $-4.53 Million -38.78%
2024-07-31 $-3.26 Million -49.35%
2023-07-31 $-2.18 Million -290.43%
2022-07-31 $-559.58K -27.06%
2021-07-31 $-440.39K -24086.55%
2020-07-31 $1.84K -99.77%
2019-07-31 $785.24K -89.92%
2018-07-31 $7.79 Million -20.29%
2017-07-31 $9.77 Million +53286.17%
2016-07-31 $18.30K -63.55%
2015-07-31 $50.22K -87.69%
2014-07-31 $407.98K --

Equity Component Analysis

This analysis shows how different components contribute to Global Health Clinics Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 3750291300.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (July 2025)

Component Amount Percentage
Other Components $33.17 Million %
Total Equity $-4.53 Million 100.00%

Global Health Clinics Ltd Competitors by Market Cap

The table below lists competitors of Global Health Clinics Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Global Health Clinics Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -3,262,980 to -4,528,355, a change of -1,265,375.
  • Net loss of 1,265,375 reduced equity.
  • Other factors decreased equity by 0.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-1.27 Million -27.94%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Global Health Clinics Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-07-31 $79.22 $0.00 x
2018-07-31 $2.53 $0.00 x
2019-07-31 $0.16 $0.00 x
2020-07-31 $0.00 $0.00 x
2021-07-31 $-0.01 $0.00 x
2022-07-31 $-0.06 $0.00 x
2023-07-31 $-0.23 $0.00 x
2024-07-31 $-0.35 $0.00 x
2025-07-31 $-0.48 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Global Health Clinics Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -2648.84%
  • • Asset Turnover: 0.72x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-7933.50%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2014 -60.78% 0.00% 0.00x 1.40x $-218.01K
2015 0.00% 0.00% 0.00x 0.00x $-354.18K
2016 -174.38% 0.00% 0.00x 2.57x $-33.75K
2017 -21.93% 0.00% 0.00x 1.04x $-3.12 Million
2018 -40.36% 0.00% 0.00x 1.04x $-3.92 Million
2019 -2076.33% -3341.93% 0.38x 1.62x $-16.38 Million
2020 -92828.27% -483.99% 0.62x 307.11x $-1.70 Million
2021 0.00% -3766.83% 0.37x 0.00x $-8.43 Million
2022 0.00% -932.61% 0.25x 0.00x $-1.31 Million
2023 0.00% -1580.10% 0.43x 0.00x $-1.41 Million
2024 0.00% -1299.62% 2.83x 0.00x $-751.91K
2025 0.00% -2648.84% 0.72x 0.00x $-812.54K

Industry Comparison

This section compares Global Health Clinics Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $439,452,927
  • Average return on equity (ROE) among peers: -31.68%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Global Health Clinics Ltd (LRSNF) $-4.86 Million -60.78% N/A $10.33K
Ascend Wellness Holdings Inc (AAWH) $71.80 Million -118.37% 11.54x $48.90 Million
AB Science S.A (ABSCF) $-21.01 Million 0.00% 0.00x $39.89 Million
Alterola Biotech Inc (ABTI) $-294.68K 0.00% 0.00x $603.58K
Aurora Cannabis Inc (ACB) $521.74 Million -156.52% 0.78x $195.20 Million
Acreage Holdings Inc (ACRDF) $494.79 Million -30.37% 0.40x $13.48K
Acura Pharmaceuticals Inc (ACUR) $29.91 Million 0.00% 0.07x $13.20K
Agra Ventures Ltd. (AGFAF) $1.72 Million -18.78% 0.11x $298.23K
Allergy Therapeutics plc (AGYTF) $20.08 Million -10.91% 0.33x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $21.19 Million 12.93% 1.96x $1.85
Adcock Ingram Holdings Limited (AIHLF) $3.25 Billion 5.19% 0.72x $85.61 Million